MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine dysregulation syndrome"

  • 2026 International Congress

    Beyond Parkinson’s Disease, Impulse Control Dysregulation: The Psychosocial Correlates of Problematic Internet Use

    T. Adeoye, O. Buhari, O. Adeoye (Ogbomoso, Nigeria)

    Objective: To determine the prevalence of problematic internet use and associated psychosocial correlates as a phenotype of impulse control dysregulation among undergraduates. Background: Impulse control…
  • 2026 International Congress

    Clinical Approach to Impulse Control–Related Behavioural Disorders in Parkinson’s Disease: A Scoping Review

    G. Jin Yi, C. Lai Gwen, F. Cardoso, L. Tan (Singapore, Singapore)

    Objective: We aimed to summarize the definitions, underlying neurobiological mechanisms, validated assessment tools (for both screening and rating), management strategies, and future directions for each…
  • 2026 International Congress

    Nutritional Status Assessment in Patients with Parkinson’s Disease

    MB. Charra Castellani, A. Silva, A. Gomez, M. Roldan, V. Kurtz, E. Knorre, D. Ballesteros (Buenos Aires, Argentina)

    Objective: To evaluate the nutritional status of patients with Parkinson's disease (PD) and identify the clinical, psychosocial, and nutritional factors associated with it. Background: Malnutrition…
  • 2025 International Congress

    Down-titration of levodopa complicated by catatonia

    D. Newbold, . (New York, USA)

    Objective: Provide evidence that reductions in levodopa can trigger catatonia Background: Dopamine dysregulation syndrome (DDS) occurs when patients crave and self-up-titrate levodopa, often leading to…
  • 2024 International Congress

    Two unusual cases of dopamine dysregulation syndrome in patients with Parkinson’s disease

    L. Lachance, P. Huot (Montreal, Canada)

    Objective: To present two cases of dopamine dysregulation syndrome (DDS) in patients with Parkinson’s disease (PD) who took extreme measures to access more dopaminergic medication.…
  • 2024 International Congress

    Dopamine Dysregulation Syndrome Outcomes following Pallidal Deep Brain Stimulation in Parkinson’s Disease

    N. David, S. Factor, R. Tripathi, L. Higginbotham (Atlanta, USA)

    Objective: To examine the impact of pallidal deep brain stimulation (DBS) on symptoms of Dopamine Dysregulation Syndrome (DDS) in Parkinson’s disease (PD). Background: DDS is…
  • 2024 International Congress

    Dopamine Dysregulation in Parkinson’s Disease and Substance Use: Therapeutic Use and Compulsive Behaviors Thin Line

    J. Hall, R. Islam, D. Nolasco, B. Carr (GAINESVILLE, USA)

    Objective: Parkinson's Disease (PD) inherently disrupts dopaminergic transmission, primarily within the nigrostriatal pathway, necessitating dopaminergic therapies. However, these therapies can lead to Dopamine Dysregulation Syndrome…
  • 2023 International Congress

    Impulse Control Disorder and medication management in Patients with Early-Onset Parkinson’s Disease

    J. Jacobson, K. Ghoniem, A. Mullan, P. Turcano, C. Stang, E. Camerucci, C. Piat, J. Bower, R. Savica (Rochester, USA)

    Objective: To assess the usage frequency of dopamine agonists (DA), the prevalence of impulse control disorder (ICD) in patients with Early-onset Parkinson’s Disease (EOPD), and…
  • 2023 International Congress

    Dopamine dysregulation syndrome in Parkinson’s disease controlled by safinamine

    SK. Song, JH. Kang (Jeju-Si, Republic of Korea)

    Objective: To describe a case of dopamine dysregulation syndrome managed by safinamide. Background: Dopamine dysregulation syndrome (DDS) is an uncommon non-motor symptom of Parkinson disease…
  • 2022 International Congress

    Predictors of relapse in impulse control disorders in patients with Parkinson’s disease.

    L. Gaibor, D. Vazquez, H. Estrada (CDMX, Mexico)

    Objective: Identify predictors of relapse in impulse control disorders (ICD) in patients with Parkinson's disease. Background: Behaviors that are performed repeatedly, excessively or minimally and…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley